Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):552–561. doi: 10.1097/QAI.0000000000002067

Table 7:

Initial prescription for HTN management among PLHIV diagnosed with HTN (N=192)

Treatment modality Initial HTN Prescription Frequency (n =192) Percentage
Medicines for HTN treatment (N=181, 94.3%)
CCB + ACEI 69 35.9
CCB + Beta blocker 26 13.5
CCB 22 11.5
CCB + Thiazide diuretic 21 10.9
CCB + ARB 18 9.4
Thiazide diuretic + Beta blocker 16 8.3
Thiazide diuretic + ARB 3 1.6
CCB + Thiazide diuretic + Furosemide 2 1.0
Other medicines combinations 4 2.1
Lifestyle modification (N=11, 5.7%)
Lifestyle modification 11 5.7

CCB= Calcium channel blocker, ACEI=Angiotensin converting enzyme inhibitors, ARB=angiotensin receptor blocker